Skip Navigation

Health: Drug development

pharmaCoMalariavaccine_shanghai_whotdrcrump

A rising generics industry in developing nations is helping secure access to cheap drugs for the world's poor. But controversies over patent rules could divert investment from already neglected diseases.

(Photo credit: WHO/TDR/Crump)

Opinions and Analysis

Drug-resistant TB needs massive research increase

Multidrug-resistant TB needs more research to equip healthcare workers with the right tools, write Frank G. J. Cobelens and colleagues.

17 July 2008 | EN | 中文
Source: PLoS Medicine

It's a long road to a H5N1 vaccine stockpile

Tadataka Yamada, Alice Dautry and Mark Walport want to see better coordination and financing for a global H5N1 virus vaccine stockpile.

14 July 2008 | EN | 中文
Source: Nature

Research deficiencies 'delaying HIV prevention'

16 April 2008 | EN | 中文
Source: New England Journal of Medicine


News and Features

Antimalarials New antimalarials 'within next two years'

The Medicines for Malaria Venture plans to roll out three new antimalarials by 2010, according to its new five-year plan.

2 October 2008 | EN

Artemisinin annua Low-cost antimalarials 'on the horizon'

Cheaper medicines for malaria are on the horizon with new and faster genetic techniques, say scientists.

1 October 2008 | EN